Folic acid 5mg tablets for use during pregnancy

Published Last updated See all updates

SPS PGD template for the supply of folic acid 5mg tablets to reduce risk of neural tube defect or compensate for increased folate demand during pregnancy.

Provenance

Developed by SPS and NHS England with the support of specialists working within clinical practice for medicines commonly supplied for the prevention of complications in pregnancy and endorsed by the National Clinical Director for Maternity NHS England.

PGD template attachment

The template PGDs are attached below to download and use in conjunction with our implementation advice.

Version 2.0 published

Version 2.0 of this PGD template has been published and is valid for use from February 2025. It has been published in advance of its valid from date to allow organisations time to take it through local governance processes.

Version 1.0 remains valid until the end of January 2025 – it will be removed from this webpage on expiry.

Attachments

More pregnancy and supportive medicines PGD templates

All PGD templates

Templates

National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

Update history

  1. Version 2.0 for use from 1st February 2025 published
  1. Title, URL and summary amended.
  1. Published

Print this page